Analysts’ Top Financial Picks: Deutsche Bank AG (DB), Pardes Biosciences (PRDS)

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Deutsche Bank AG (DBResearch Report) and Pardes Biosciences (PRDSResearch Report) with bullish sentiments.

Deutsche Bank AG (DB)

J.P. Morgan analyst Kian Abouhossein maintained a Buy rating on Deutsche Bank AG today and set a price target of EUR16.00. The company’s shares closed last Thursday at $10.86.

According to TipRanks.com, Abouhossein is a 5-star analyst with an average return of 14.4% and a 56.3% success rate. Abouhossein covers the Financial sector, focusing on stocks such as Goldman Sachs Group, Morgan Stanley, and UBS Group AG.

Currently, the analyst consensus on Deutsche Bank AG is a Moderate Buy with an average price target of $14.94, which is a 38.2% upside from current levels. In a report issued on March 3, Kepler Capital also upgraded the stock to Buy with a EUR15.50 price target.

See the top stocks recommended by analysts >>

Pardes Biosciences (PRDS)

Jefferies analyst Dennis Ding maintained a Buy rating on Pardes Biosciences yesterday and set a price target of $25.00. The company’s shares closed last Thursday at $6.44, close to its 52-week low of $5.54.

According to TipRanks.com, Ding is ranked #6535 out of 7798 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pardes Biosciences with a $25.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on DB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed